February 14, 2012—Reviewing cumulative dosing across care sites for activated anthracyclines chemotherapy medication orders
The Chemo Order Entry values for cumulative dosing are derived from activated anthracyclines chemotherapy medication orders. The information does not reflect ACTUAL doses administered. The dosing is listed separately for the same medication when it has been ordered with different dosing units—for example, mg/kg (milligrams of medication per kilogram of patient weight) and mg/m2 (milligrams of medication per square meter of patient body surface area). The display includes a link to open the oncology treatment history for the patient in the LMR (Longitudinal Medical Record).
Orders included in the data:
All Dana Farber Partners Cancer Care (DFPCC) sites—MGH inpatient and ambulatory, Dana Farber (DFCI), and BWH inpatient and ambulatory locations
Activated orders only—no orders awaiting activation
Anthracyclines Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, and Mitoxantrone for adult and pediatric patients, and Bleomycin for pediatric patients only
Duplicates, change to orders and discontinue orders; if there is more than one activation for the same chemo medication, for the same date, the higher dose is displayed
Instructions—The Cumulative Dose button is accessible from the current Chemo orders list, the regimen/protocol selection form, and the chemo regimen/protocol player. See Evaluating Cumulative Dose Information.
See also: